Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Add-on Reparixin in Adult Patients With ARDS

ClinicalTrials.gov ID: NCT05496868

Public ClinicalTrials.gov record NCT05496868. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2, Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Assess Efficacy and Safety of Reparixin as add-on Therapy to SoC in Acute Respiratory Distress Syndrome (RESPIRATIO)

Study identification

NCT ID
NCT05496868
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Dompé Farmaceutici S.p.A
Industry
Enrollment
66 participants

Conditions and interventions

Interventions

  • Matching Placebo Other
  • Reparixin 600mg Drug

Other · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 5, 2022
Primary completion
Mar 17, 2025
Completion
Apr 17, 2025
Last update posted
May 10, 2026

2022 – 2025

United States locations

U.S. sites
33
U.S. states
21
U.S. cities
32
Facility City State ZIP Site status
The University of Alabama at Birmingham Hospital Birmingham Alabama 35233
Banner - University Medical Center Phoenix Phoenix Arizona 85006
University of Southern California Los Angeles California 90033
University of California Irvine Health Orange California 92868
Unversity of California Davis Medical Center Sacramento California 95817
Denver Health Denver Colorado 80204
University of South Florida Tampa Florida 33606
Emory Saint Joseph's Hospital Atlanta Georgia 30342
Methodist Hospitals of Northwest Indiana Gary Indiana 46404
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Newton Wellesley Hospital Newton Massachusetts 02462-1607
Baystate Health Springfield Massachusetts 01107
Detroit Medical Center Detroit Michigan 48201
Henry Ford Hospital Detroit Michigan 48202
MyMichigan Medical Center Midland Midland Michigan 48670
William Beaumont Hospital Royal Oak Michigan 48073
Jackson Pulmonary Associates Jackson Mississippi 39202
University of Missouri Health Care Columbia Missouri 65212
Hackensack Meridian Health Hackensack New Jersey 07601
NYU Langone Brooklyn Brooklyn New York 11220
New York University Langone Health New York New York 10016
The Cleveland Clinic Foundation Cleveland Ohio 44195
The Ohio State University Wexner Medical Center Columbus Ohio 43210
University of Oklahoma Medical Center Oklahoma City Oklahoma 73104
Oregon Health and Science University Portland Oregon 97239
University of Tennessee Medical Center Knoxville Tennessee 37920
Baptist Hospitals of Southeast Texas Beaumont Texas 77701
University of Texas Southwestern Medical Center Dallas Texas 75390-8894
Cardiovoyage Denison Texas 75020
Houston Methodist Hospital Houston Texas 77030
University of Utah Hospitals & Clinics Salt Lake City Utah 84108
Virginia Commonwealth University Health System Richmond Virginia 23298
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05496868, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 10, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05496868 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →